Oramed Pharmaceuticals Inc (ORMP)
2.33
+0.06
(+2.64%)
USD |
NASDAQ |
Apr 22, 16:00
Oramed Pharmaceuticals Cash from Operations (TTM): -10.30M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -10.30M |
| September 30, 2023 | -16.94M |
| June 30, 2023 | -18.49M |
| March 31, 2023 | -24.34M |
| December 31, 2022 | -27.92M |
| September 30, 2022 | -26.76M |
| June 30, 2022 | -30.66M |
| March 31, 2022 | -27.81M |
| November 30, 2021 | -21.93M |
| August 31, 2021 | -21.18M |
| May 31, 2021 | -17.50M |
| February 28, 2021 | -15.22M |
| November 30, 2020 | -15.60M |
| August 31, 2020 | -12.44M |
| May 31, 2020 | -13.25M |
| February 29, 2020 | -13.55M |
| November 30, 2019 | -11.80M |
| August 31, 2019 | -12.94M |
| May 31, 2019 | -14.32M |
| February 28, 2019 | -14.47M |
| November 30, 2018 | -16.06M |
| August 31, 2018 | -14.66M |
| May 31, 2018 | -12.06M |
| February 28, 2018 | -10.61M |
| November 30, 2017 | -10.06M |
| Date | Value |
|---|---|
| August 31, 2017 | -5.831M |
| May 31, 2017 | 3.02M |
| February 28, 2017 | 3.151M |
| November 30, 2016 | 8.40M |
| August 31, 2016 | 4.655M |
| May 31, 2016 | -3.177M |
| February 29, 2016 | -1.866M |
| November 30, 2015 | -5.794M |
| August 31, 2015 | -4.946M |
| May 31, 2015 | -4.719M |
| February 28, 2015 | -4.841M |
| November 30, 2014 | -4.719M |
| August 31, 2014 | -4.068M |
| May 31, 2014 | -3.547M |
| February 28, 2014 | -3.560M |
| November 30, 2013 | -3.351M |
| August 31, 2013 | -3.396M |
| May 31, 2013 | -3.457M |
| February 28, 2013 | -3.291M |
| November 30, 2012 | -2.610M |
| August 31, 2012 | -2.301M |
| May 31, 2012 | -2.381M |
| February 29, 2012 | -2.086M |
| November 30, 2011 | -1.692M |
| August 31, 2011 | -1.706M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-30.66M
Minimum
Jun 2022
-10.30M
Maximum
Dec 2023
-18.58M
Average
-16.94M
Median
Sep 2023
Cash from Operations (TTM) Benchmarks
| Inogen Inc | -3.234M |
| Petros Pharmaceuticals Inc | -7.626M |
| DIH Holding US Inc | -- |
| NovaBay Pharmaceuticals Inc | -4.131M |
| Palatin Technologies Inc | -26.54M |